Chapter 20 study guide Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Identify the contributions of Paul Ehrlich and Alexander Fleming to Chemotherapy

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Recognize the types of microbes that produce most antibiotics

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Discuss the reasons why the number of antibiotic discoveries has decreased in recent years

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is selective toxicity?

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is chemotherapy?

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define spectrum of activity

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is broad-spectrum antibiotic

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Define superinfection

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Define the words bacteriocidal and bacteriostatic

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Recognize the different drugs that can be classified as antibiotics depending o how “antibiotic is defined

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe how ICHIP was used to identify the bacterium production teixobactin and why this approach may facilitate the discovery of additional antibiotics

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Identify factors that determine the selective toxicity of anti-microbials

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss the advantages and disadvantages of broad and narrow-spectrum antimicrobials when treating infections

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Identify the different modes of action of antimicrobial drugs

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name and distinguish all antimicrobrial drug classes and the individual antimicrobial members within each class provided in these slides

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Distinguish Beta-lactam antibiotics from those that target other aspects of bacterial cell wall synthesis

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Discuss the two natural penicillin that are used clinically; their characteristics, usage and disadvantages.

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Explain how penicillin G can be better retained in the body

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Identify semisynthetic penicillin’s and discuss how they are synthesized and how they extend antibiotic spectrum and increase resistance to penicillinase

A

a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Identify Beta-lactamase inhibitor and explain its properties and use.

A

A

21
Q

Provide the complete phrases for acronyms MRSA, VRSA, and VRE, and discuss the usage of these acronyms with respect to increasing antibiotic resistance

A

A

22
Q

Compare and contrast the Carbipenim, Monbactam and Cephalosporin Beta-lactam classes with each other, with penicillin and other antimicrobials presented in the slides

A

A

23
Q

Compare and contrast the polypeptide bacterial cell wall inhibitors (Bacitracin and Vancomycin0 with each other, the B-lactam classes and other antimicrobial presented in slides

A

A

24
Q

Compare and contrast the mycobacterial cell wall inhibitors (Isoniazid and Ethambutol) with each other, the b-lactam classes and other antimicrobials presented in the slides

A

A

25
Q

Compare and contrast the bacterial protein synthesis inhibitor classes with each other and other antimicrobials presented in slides

A

A

26
Q

Compare and contrast the bacterial plasma membrane inhibitors with each other, and other antimicrobials presented in the slides

A

A

27
Q

Distinguish between Type I and II fatty acid synthetases

A

A

28
Q

Compare and contrast the bacterial nucleic acid synthesis inhibitors with each other and all antimicrobials presented in the slides

A

A

29
Q

Describe the properties of sulfa drugs, how they inhibit microbial growth, and why they are used in combination with trimethoprim

A

A

30
Q

Explain modes of action of current antifungal drugs

A

A

31
Q

Compare and contrast the anti-fungal drugs that target ergosterol itself, its synthesis with each other, and all other antimicrobials presented in the slides

A

A

32
Q

Describe the composition of yeast cell wall

A

A

33
Q

Name the anti-fungal class and drug that targets fungal cell wall synthesis, and compare and contrast it with the antimicrobials presented in the slides

A

A

34
Q

Name the target and explain the mechanism of action of flucytosine

A

A

35
Q

Name and describe the anti-fungal drugs that don’t target ergosterol or cell wall synthesis

A

a

36
Q

Explain modes of action of current antiviral drugs

A

a

37
Q

Name the target and explain the mechanism of action of acyclovir

A

A

38
Q

Name the inhibitors of the influenza virus enzyme neuraminidase

A

A

39
Q

Discuss the use of infections

A

A

40
Q

Discuss the different ways that HIV antivirals inhibit HIV infection

A

A

41
Q

Name and describe the two anti-protozoan drugs presented in the slides

A

A

42
Q

Describe the tests for antimicrobial effectiveness, be able to interpret resulting the data, and explain how this data is used for treatment

A

A

43
Q

Distinguish between MIC and MBC and explain why it is important for a physician to know these values

A

A

44
Q

Describe the mechanisms of drug resistance

A

A

45
Q

Compare and contrast synergism and antagonism

A

A

46
Q

Explain the types of antibiotic misuses that select for resistance mutants

A

A

47
Q

Define and be able to calculate therapeutic index and understand its significance

A

A

48
Q

Explain why prescribing multiple drugs can be problematic

A

A

49
Q

Describe antimicrobial peptides and phage therapy

A

A